Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal of Proteomics
|
September 6, 2011
SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration
Ann Westman-Brinkmalm, Alexandra Abramsson, Josef Pannee, et al.
Journal of Alzheimer'S Disease : JAD
|
October 19, 2012
A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls
Josef Pannee, Erik Portelius, Madalina Oppermann, et al.
Neuroscience Letters
|
May 7, 2014
The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease
Josef Pannee, Ulrika Törnqvist, Anni Westerlund, et al.
Molecular Neurodegeneration
|
February 22, 2017
Ex vivo <sup>18</sup>O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
Erik Portelius, Niklas Mattsson, Josef Pannee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 25, 2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry
Josef Pannee, Johan Gobom, Leslie M Shaw, et al.
Clinical Chemistry and Laboratory Medicine
|
June 28, 2018
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
Ulf Andreasson, Julia Kuhlmann, Josef Pannee, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 25, 2016
CSF Aβ<sub>1-42</sub> - an excellent but complicated Alzheimer's biomarker - a route to standardisation
Julia Kuhlmann, Ulf Andreasson, Josef Pannee, et al.
Brain : a Journal of Neurology
|
July 13, 2016
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
Antoine Leuzy, Konstantinos Chiotis, Steen G Hasselbalch, et al.
Brain : a Journal of Neurology
|
April 23, 2021
Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype
Antoinette O'Connor, Josef Pannee, Teresa Poole, et al.
Clinical Chemistry and Laboratory Medicine
|
October 27, 2015
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
Maria Bjerke, Ulf Andreasson, Julia Kuhlmann, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal of Proteomics
|
September 6, 2011
SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration
Ann Westman-Brinkmalm, Alexandra Abramsson, Josef Pannee, et al.
Journal of Alzheimer'S Disease : JAD
|
October 19, 2012
A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls
Josef Pannee, Erik Portelius, Madalina Oppermann, et al.
Neuroscience Letters
|
May 7, 2014
The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease
Josef Pannee, Ulrika Törnqvist, Anni Westerlund, et al.
Molecular Neurodegeneration
|
February 22, 2017
Ex vivo <sup>18</sup>O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
Erik Portelius, Niklas Mattsson, Josef Pannee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 25, 2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry
Josef Pannee, Johan Gobom, Leslie M Shaw, et al.
Clinical Chemistry and Laboratory Medicine
|
June 28, 2018
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
Ulf Andreasson, Julia Kuhlmann, Josef Pannee, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 25, 2016
CSF Aβ<sub>1-42</sub> - an excellent but complicated Alzheimer's biomarker - a route to standardisation
Julia Kuhlmann, Ulf Andreasson, Josef Pannee, et al.
Brain : a Journal of Neurology
|
July 13, 2016
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
Antoine Leuzy, Konstantinos Chiotis, Steen G Hasselbalch, et al.
Brain : a Journal of Neurology
|
April 23, 2021
Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype
Antoinette O'Connor, Josef Pannee, Teresa Poole, et al.
Clinical Chemistry and Laboratory Medicine
|
October 27, 2015
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
Maria Bjerke, Ulf Andreasson, Julia Kuhlmann, et al.
Page
of 3